Source: EIN Presswire

Press Release: Igyxos : Igyxos Biotherapeutics to Attend BIO International Convention 2024

NOUZILLY, FRANCE, May 29, 2024 /⁨EINPresswire.com⁩/ -- Igyxos Biotherapeutics ("Igyxos" or "the Company"), an emerging biopharmaceutical company specializing in infertility solutions, is pleased to announce its participation in the upcoming 2024 BIO ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Emmanuel Dulac's photo - CEO of Igyxos

CEO

Emmanuel Dulac

CEO Approval Rating

82/100

Read more